MX2012000434A - Metodo de sanacion de herida y modulacion de cicatriz. - Google Patents
Metodo de sanacion de herida y modulacion de cicatriz.Info
- Publication number
- MX2012000434A MX2012000434A MX2012000434A MX2012000434A MX2012000434A MX 2012000434 A MX2012000434 A MX 2012000434A MX 2012000434 A MX2012000434 A MX 2012000434A MX 2012000434 A MX2012000434 A MX 2012000434A MX 2012000434 A MX2012000434 A MX 2012000434A
- Authority
- MX
- Mexico
- Prior art keywords
- wound healing
- scar
- modulation
- corticosteroids
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se relaciona a métodos para promover la sanación de herida y reducción de la formación de cicatriz mediante la administración de corticosteroides, y composiciones farmacéuticas que comprenden corticosteroides.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22440809P | 2009-07-09 | 2009-07-09 | |
US22621609P | 2009-07-16 | 2009-07-16 | |
PCT/US2010/041576 WO2011006100A1 (en) | 2009-07-09 | 2010-07-09 | Method of wound healing and scar modulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012000434A true MX2012000434A (es) | 2012-04-11 |
Family
ID=43427950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012000434A MX2012000434A (es) | 2009-07-09 | 2010-07-09 | Metodo de sanacion de herida y modulacion de cicatriz. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110009374A1 (es) |
EP (1) | EP2451280A4 (es) |
JP (1) | JP2012532889A (es) |
CN (1) | CN102480969A (es) |
AR (1) | AR077410A1 (es) |
AU (1) | AU2010271205A1 (es) |
BR (1) | BR112012001098A2 (es) |
CA (1) | CA2767661A1 (es) |
MX (1) | MX2012000434A (es) |
WO (1) | WO2011006100A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100322875A1 (en) | 2009-06-18 | 2010-12-23 | Advanced Bio-Technologies, Inc. | Silicone scar treatment preparation |
US8623040B2 (en) | 2009-07-01 | 2014-01-07 | Alcon Research, Ltd. | Phacoemulsification hook tip |
WO2012012390A1 (en) | 2010-07-19 | 2012-01-26 | Marvphyt Development Llc | Botanical composition and methods of manufacture and use |
US10258505B2 (en) | 2010-09-17 | 2019-04-16 | Alcon Research, Ltd. | Balanced phacoemulsification tip |
ITMI20111050A1 (it) | 2011-06-10 | 2012-12-11 | Sevecom Spa | Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali. |
RU2665946C2 (ru) | 2011-06-24 | 2018-09-05 | Мерц Фарма Гмбх Унд Ко. Кгаа | Композиция, содержащая луковый экстракт и липосомы |
US9364510B2 (en) | 2011-07-19 | 2016-06-14 | Marvphyt Development Llc | Botanical composition and methods of manufacture and use |
CN110372673B (zh) | 2011-07-29 | 2023-10-03 | 卡尔约药物治疗公司 | 含酰肼的核运输调节剂及其用途 |
AU2012308530B2 (en) * | 2011-09-13 | 2016-04-21 | Brigham Young University | Products for healing of tissue wounds |
US9474685B2 (en) | 2011-09-28 | 2016-10-25 | Sure-Shot Medical Device Inc. | Apparatus for localized dermatological treatment |
GB201120724D0 (en) * | 2011-12-01 | 2012-01-11 | Gauthier Rene | System and method for alleviating the appearance of scars and/or scar tissue |
FR2985064B1 (fr) * | 2011-12-23 | 2016-02-26 | Oreal | Procede pour delivrer un conseil cosmetique |
CN104271160B (zh) * | 2012-04-27 | 2017-08-08 | 道康宁公司 | 包含基于有机硅的赋形剂以将活性物质递送到基底的局部用制剂组合物 |
ES2702279T3 (es) | 2012-05-09 | 2019-02-28 | Biogen Ma Inc | Moduladores del transporte nuclear y usos de los mismos |
US11458199B2 (en) * | 2012-08-21 | 2022-10-04 | Opko Pharmaceuticals, Llc | Liposome formulations |
US9808654B2 (en) * | 2013-02-11 | 2017-11-07 | Jan Marini Skin Research | Post procedure skin care gel and methods of use thereof |
US10202366B2 (en) * | 2013-03-15 | 2019-02-12 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using CRM1 inhibitors |
US9880908B2 (en) * | 2013-04-23 | 2018-01-30 | Hewlett-Packard Development Company, L.P. | Recovering from compromised system boot code |
ME03421B (me) | 2013-06-21 | 2020-01-20 | Karyopharm Therapeutics Inc | 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba |
US11432990B2 (en) | 2013-08-30 | 2022-09-06 | ISOS Solutions, LLC | Textured apparatus with therapeutic material incorporated therein and methods of manufacturing same |
US9226890B1 (en) | 2013-12-10 | 2016-01-05 | Englewood Lab, Llc | Polysilicone base for scar treatment |
US10423552B2 (en) * | 2013-12-23 | 2019-09-24 | Intel Corporation | Integrated component interconnect |
WO2015189712A2 (en) | 2014-06-09 | 2015-12-17 | Klox Technologies Inc. | Silicone-based biophotonic compositions and uses thereof |
PE20170138A1 (es) | 2014-07-21 | 2017-03-16 | Sevecom Spa | Emulsionante en polvo para alimentos para animales |
EP4112615A1 (en) | 2014-08-15 | 2023-01-04 | Karyopharm Therapeutics Inc. | Compositions comprising one crystalline form of selinexor |
EP3397634A1 (en) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
MA43529A (fr) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics Inc | Modulateurs de transport nucléaire et leurs utilisations |
WO2018098472A1 (en) | 2016-11-28 | 2018-05-31 | Karyopharm Therapeutics Inc. | Crm1 inhibitors for treating epilepsy |
JP2020502070A (ja) | 2016-11-30 | 2020-01-23 | ケース ウエスタン リザーブ ユニバーシティ | 15−pgdh阻害剤とコルチコステロイドおよび/またはtnf阻害剤との組み合わせならびにその使用 |
EP3576737A4 (en) | 2017-02-06 | 2021-04-21 | Case Western Reserve University | COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF SHORT CHAIN DEHYDROGENASE |
CN113453670A (zh) * | 2018-09-28 | 2021-09-28 | 乔·斯图丁 | 类固醇和大分子的透孔递送 |
US20200397720A1 (en) * | 2019-06-23 | 2020-12-24 | Charles Huntington Gallina | Method and formulation for treatment of wounds by new tissue regeneration with reduced trauma and scar tissue formation |
CN110368498A (zh) * | 2019-08-26 | 2019-10-25 | 瑞希(重庆)生物科技有限公司 | 一种促进伤口愈合的制剂及其制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6337076B1 (en) * | 1999-11-17 | 2002-01-08 | Sg Licensing Corporation | Method and composition for the treatment of scars |
KR100362924B1 (ko) * | 2000-01-11 | 2002-11-30 | 주식회사 동구약품 | 외피용약제 조성물 |
EP1286649A1 (en) * | 2000-05-23 | 2003-03-05 | Unilever Plc | Deodorant and/or antiperspirant compositions |
GB0018466D0 (en) * | 2000-07-27 | 2000-09-13 | Strakan Pharm Ltd | Keloid Treatment |
US6610322B1 (en) * | 2000-12-20 | 2003-08-26 | Brian Charles Keller | Self forming, thermodynamically stable liposomes and their applications |
US6495596B1 (en) * | 2001-03-23 | 2002-12-17 | Biozibe Laboratories, Inc. | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2 |
US6998421B2 (en) * | 2001-06-07 | 2006-02-14 | Biozone Laboratories, Inc. | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2 |
JP4450545B2 (ja) * | 2001-07-05 | 2010-04-14 | ロート製薬株式会社 | エアゾール製剤 |
JP4549006B2 (ja) * | 2002-05-07 | 2010-09-22 | ロート製薬株式会社 | ゲル軟膏 |
GB0216427D0 (en) * | 2002-07-16 | 2002-08-21 | Advanced Biotechnologies Inter | Wound dressing |
US20040220155A1 (en) * | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
WO2005009342A2 (en) * | 2003-07-16 | 2005-02-03 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
KR20070027587A (ko) * | 2004-06-17 | 2007-03-09 | 갈데르마 소시에떼아노님 | 실리콘제, 코르티코스테로이드 및 비타민 d 또는 이의유도체를 함유하는 건선 치료용 조성물 |
RU2008100037A (ru) * | 2005-06-10 | 2009-07-20 | Галдерма С.А. (Ch) | Способ регулируемого высвобождения лекарственного средства через кожу |
MX2009009557A (es) * | 2007-03-08 | 2010-08-10 | Crescendo Therapeutics Llc | Formulaciones de aposito para prevenir o reducir la cicatrizacion. |
US20080317830A1 (en) * | 2007-06-25 | 2008-12-25 | Liolabs Llc | Compositions and Methods for the Treatment of Wounds and Scar Tissue |
DE102009030931A1 (de) * | 2009-06-24 | 2010-12-30 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Chirurgisches Wundverschlusselement |
-
2010
- 2010-07-09 EP EP10797937A patent/EP2451280A4/en not_active Withdrawn
- 2010-07-09 CN CN2010800392366A patent/CN102480969A/zh active Pending
- 2010-07-09 US US12/833,902 patent/US20110009374A1/en not_active Abandoned
- 2010-07-09 WO PCT/US2010/041576 patent/WO2011006100A1/en active Application Filing
- 2010-07-09 JP JP2012519777A patent/JP2012532889A/ja active Pending
- 2010-07-09 MX MX2012000434A patent/MX2012000434A/es not_active Application Discontinuation
- 2010-07-09 AU AU2010271205A patent/AU2010271205A1/en not_active Abandoned
- 2010-07-09 BR BRBR112012001098-0A patent/BR112012001098A2/pt not_active IP Right Cessation
- 2010-07-09 CA CA2767661A patent/CA2767661A1/en not_active Abandoned
- 2010-07-12 AR ARP100102522A patent/AR077410A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010271205A1 (en) | 2012-02-09 |
BR112012001098A2 (pt) | 2015-09-01 |
AR077410A1 (es) | 2011-08-24 |
JP2012532889A (ja) | 2012-12-20 |
US20110009374A1 (en) | 2011-01-13 |
EP2451280A1 (en) | 2012-05-16 |
CN102480969A (zh) | 2012-05-30 |
WO2011006100A1 (en) | 2011-01-13 |
EP2451280A4 (en) | 2012-12-26 |
CA2767661A1 (en) | 2011-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012000434A (es) | Metodo de sanacion de herida y modulacion de cicatriz. | |
AU2018236800B2 (en) | DNA-PK inhibitors | |
MY163031A (en) | Method of treating obesity using antioxidant inflammation modulators | |
PH12017500864A1 (en) | Anti-notch1 antibodies | |
IN2012DN03883A (es) | ||
MX2011007930A (es) | Conjugados de insulina cristalina. | |
MY164356A (en) | Substituted 5-fluoro-1h-pyrazolopyridines and their use | |
IN2012DN02081A (es) | ||
EP2418945A4 (en) | Mineral salt-sulfuric acid compositions and methods for their use | |
WO2012125544A3 (en) | Necroptosis inhibitors and methods of use therefor | |
EP3715457A3 (en) | Modulation of prekallikrein (pkk) expression | |
UA105487C2 (uk) | Заміщені дигідропіразолони як інгібітори hif-проліл-4-гідроксилази | |
ZA201304940B (en) | Granzyme b inhibitor compositions, methods and uses for promoting wound healing | |
CA2878796C (en) | Derivatives of pyridinone as inhibitors for tissue transglutaminase | |
PH12015502405B1 (en) | Methods and compositions for wound healing | |
MX2015007719A (es) | Terapia dirigida del receptor del factor de crecimiento epidermico (egfr) de trastornos neurologicos y dolor. | |
MX357166B (es) | Anticuerpos que se unen a notum pectinacetilesterasa. | |
MX339361B (es) | Derivados de alternano. | |
MX2011009277A (es) | Composicion de leucocito activada. | |
MX2013002539A (es) | Sobrenadante condicionado por leucocitos activados y usos para la cicatrizacion de heridas. | |
WO2011136513A3 (ko) | 디히드록시벤조산 유도체를 포함하는 골이식용 또는 골충진용 조성물 | |
WO2012082942A3 (en) | Neuropeptide analogs, compositions, and methods for treating pain | |
IN2014DN03010A (es) | ||
WO2011116351A3 (en) | Methods and compositions for the treatment of cancer | |
WO2015050686A3 (en) | Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of company name or juridical status |
Owner name: ABBVIE INC. |
|
FA | Abandonment or withdrawal |